Oncternal Therapeutics, Inc.
NASDAQ:ONCT
7.09 (USD) • At close July 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.785 | 1.49 | 4.315 | 3.375 | 2.425 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.739 | 60.613 | 14.73 | 13.528 | 7.126 | 7.505 | 3.782 | 1.867 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 29.753 | 0.179 | 0.169 | 12 | 10.159 | 0 | 0 | 2.511 | 0 | 0 | 0 | 0 | 1.055 | 0.768 | 1.29 | 0.649 | 0.621 | 0.773 | 1.573 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -28.968 | 1.311 | 4.146 | -8.625 | -7.734 | 0 | 0 | -2.511 | 0 | 0 | 0 | 0 | 13.684 | 59.845 | 13.44 | 12.879 | 6.505 | 6.732 | 2.209 | 1.867 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| -36.902 | 0.88 | 0.961 | -2.556 | -3.189 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0.928 | 0.987 | 0.912 | 0.952 | 0.913 | 0.897 | 0.584 | 1 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 29.753 | 32.98 | 24.086 | 12.544 | 10.159 | 29.669 | 21.467 | 17.228 | 13.607 | 20.87 | 32.318 | 38.887 | 31.938 | 28.495 | 32.344 | 44.259 | 38.508 | 33.897 | 30.923 | 17.95 | 10.468 | 9.285 | 5.921 | 2.679 | 0.518 |
| General & Administrative Expenses
| 12.546 | 13.457 | 11.595 | 8.373 | 7.286 | 9.39 | 9.188 | 8.705 | 8.234 | 9.478 | 11.281 | 10.845 | 0 | 17.419 | 27.749 | 23.105 | 13.501 | 11.352 | 9.845 | 7.211 | 3.512 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 12.746 | 13.457 | 11.595 | 8.373 | 7.286 | 9.39 | 9.188 | 8.705 | 8.234 | 9.478 | 11.281 | 10.845 | 15.438 | 17.419 | 27.749 | 23.105 | 13.501 | 11.352 | 9.845 | 7.211 | 3.512 | 2.405 | 2.225 | 1.203 | 0.256 |
| Other Expenses
| 0 | -1.49 | -4.315 | -3.375 | -2.425 | 0.641 | 0.216 | 0.046 | 0.057 | -0.259 | 1.488 | -0.019 | 15.438 | 0 | 0 | 0 | 13.501 | 11.352 | 9.845 | 7.211 | 0.357 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 42.499 | 44.947 | 31.366 | 17.542 | 15.02 | 39.059 | 30.655 | 25.933 | 21.841 | 30.348 | 43.599 | 49.732 | 47.376 | 45.914 | 60.093 | 67.364 | 52.009 | 45.249 | 40.768 | 25.161 | 14.337 | 12.022 | 8.146 | 3.962 | 0.819 |
| Operating Income
| -41.714 | -44.947 | -31.366 | -17.542 | -33.108 | -39.059 | -30.655 | -25.933 | -21.841 | -30.348 | -43.599 | -49.732 | -33.692 | 13.931 | -46.653 | -54.485 | -45.504 | -38.517 | -38.559 | -23.294 | -14.337 | -12.022 | -8.146 | -3.962 | -0.819 |
| Operating Income Ratio
| -53.139 | -30.166 | -7.269 | -5.198 | -13.653 | 0 | 0 | 10.328 | 0 | 0 | 0 | 0 | -2.286 | 0.23 | -3.167 | -4.028 | -6.386 | -5.132 | -10.195 | -12.477 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 2.235 | 0.777 | 0.033 | 0.317 | -1.08 | 0.641 | 0.216 | 8.209 | 3.138 | -9.063 | 1.488 | -0.019 | 0.398 | 1.363 | 0.159 | 2.705 | 5.145 | -74.027 | 1.72 | 17.616 | 0.143 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -39.479 | -44.17 | -31.333 | -17.225 | -34.188 | -38.418 | -30.439 | -17.724 | -18.703 | -39.411 | -42.111 | -49.751 | -33.294 | 15.294 | -46.494 | -51.78 | -40.359 | -35.51 | -36.839 | -5.678 | -95.474 | 0 | 0 | 0 | 0 |
| Income Before Tax Ratio
| -50.292 | -29.644 | -7.261 | -5.104 | -14.098 | 0 | 0 | 7.059 | 0 | 0 | 0 | 0 | -2.259 | 0.252 | -3.156 | -3.828 | -5.664 | -4.732 | -9.741 | -3.041 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -41.714 | -0.777 | -0.033 | -0.016 | -18.276 | 0.641 | -0.047 | -8.191 | -3.124 | 8.702 | -0.384 | -8.821 | -1.438 | -2.936 | -0.238 | -1.562 | 4.9 | -72.026 | 0.299 | 17.25 | -0.143 | -0.156 | 8.063 | -0.15 | -0.069 |
| Net Income
| -39.479 | -43.393 | -31.3 | -17.209 | -15.912 | -38.418 | -30.439 | -17.724 | -18.703 | -39.411 | -42.111 | -27.075 | -33.294 | 15.294 | -46.256 | -51.78 | -40.359 | -35.51 | -36.839 | -22.348 | -14.194 | -11.866 | -8.063 | -3.812 | -0.75 |
| Net Income Ratio
| -50.292 | -29.123 | -7.254 | -5.099 | -6.562 | 0 | 0 | 7.059 | 0 | 0 | 0 | 0 | -2.259 | 0.252 | -3.14 | -3.828 | -5.664 | -4.732 | -9.741 | -11.97 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -13.43 | -16.5 | -12.69 | -16.95 | -30.81 | -11.52 | -12.22 | -8.52 | -9.33 | -33.72 | -46.75 | -30.17 | -40.63 | 27.3 | -88.92 | -99.85 | -80.86 | -79.8 | -99.25 | -68.04 | -128.45 | -107.39 | -72.85 | -34.5 | -6.79 |
| EPS Diluted
| -13.43 | -16.5 | -12.69 | -16.95 | -30.81 | -11.52 | -12.22 | -8.52 | -8.86 | -33.72 | -46.75 | -30.17 | -40.63 | 27.3 | -88.92 | -99.85 | -80.86 | -79.8 | -99.25 | -65.01 | -128.45 | -107.39 | -72.85 | -34.5 | -6.79 |
| EBITDA
| -41.714 | -44.947 | -31.366 | -17.542 | -14.832 | -39.013 | -30.655 | -34.096 | -24.922 | -21.544 | -43.599 | -49.732 | -34.09 | 12.568 | -44.868 | -54.485 | -45.504 | -38.517 | -38.559 | -23.294 | -14.123 | -11.69 | -8.146 | -3.882 | -0.774 |
| EBITDA Ratio
| -53.139 | -30.166 | -7.269 | -5.198 | -6.116 | 0 | 0 | 13.579 | 0 | 0 | 0 | 0 | -2.313 | 0.207 | -3.046 | -4.028 | -6.386 | -5.132 | -10.195 | -12.477 | 0 | 0 | 0 | 0 | 0 |